Temporomandibular Disorders (TMD)

About Temporomandibular Disorders TMD

Temporomandibular disorders (TMD) are a group of common musculoskeletal conditions affecting the temporomandibular joint (TMJ), masticatory muscles, and associated structures. They are a frequent source of orofacial pain and dysfunction and most often affect adults, with a higher prevalence reported among women.

TMD typically presents with localized pain or tenderness in the jaw, face, or preauricular region, often accompanied by pain with jaw movement, restricted or asymmetric mandibular motion, and joint sounds such as clicking, popping, or crepitus. Symptoms may also include headaches, ear-related complaints (e.g., earache, fullness, tinnitus), and neck pain.

The etiology of TMD is multifactorial and reflects an interaction between mechanical loading, neuromuscular factors, central pain processing, and psychosocial influences. Contributing factors may include parafunctional behaviours (e.g., clenching, bruxism), sustained or repetitive jaw loading, trauma, postural factors, sleep disturbance, and psychological stress. Structural findings, including malocclusion or imaging abnormalities, do not consistently correlate with symptom severity or functional impact.

TMD is best understood within a biopsychosocial framework, as symptoms, recovery, and response to care are influenced by biological, psychological, and social factors. Clinical presentation and prognosis vary widely, and management should focus on pain reduction, restoration of function, and support for participation in daily life rather than correction of structural findings alone.

About CCG Care Pathways

Purpose

CCG care pathways provide structured, evidence-based guidance for clinicians delivering conservative, non-operative care for common musculoskeletal conditions. They outline key steps of the clinical encounter, support safe and appropriate decision-making, and assist with referral or co-management when indicated. Pathways are designed as practical, user-friendly tools that complement, not replace, clinical judgment.

Development

Pathways are developed using the best available evidence from high-quality clinical practice guidelines when they exist, and from systematic reviews and expert consensus when guideline evidence is limited or evolving. Content is reviewed periodically to reflect emerging research and current best practices. Input from clinicians, educators, and researchers helps ensure pathways remain relevant, aligned with real-world practice, and responsive to user needs.

Principles of Conservative Care

Musculoskeletal conditions are multifactorial and often influenced by physical, psychological, social, and environmental factors. As such, there is no one-size-fits-all approach to care. Effective management should be ethical, evidence-informed, transparent, flexible, and tailored to individual needs. Shared decision-making ensures care aligns with patient goals and values. Ongoing monitoring and outcome assessment support a person-centred approach and enable timely adjustments to care plans. Care may be delivered in-person, virtually, or through hybrid models, guided by patient preference, access, and clinical judgment.

Disclaimer

CCG care pathways are intended to support, not substitute for, professional clinical decision-making or the advice of a qualified healthcare provider. Recommendations are evidence-informed and presented in simplified, accessible language to support clinical understanding and application. Terms used throughout are not intended as formal diagnostic or billing terminology, nor are pathways prescriptive, authoritative, or regulatory.

Providers are expected to apply their clinical expertise and consult authoritative sources such as regulatory standards and policies, diagnostic classification systems (e.g., ICD-10-CA), scope-of-practice documents, continuing professional education resources, and peer-reviewed literature. Pathways may not apply to every clinical scenario and should always be interpreted in the context of individual patient needs.

Temporomandibular Disorders (TMD) Care Pathway

1. Record Keeping

Accurate, timely, and comprehensive documentation is an essential component of high-quality, evidence-based care. Clinical records must clearly reflect patient interactions, clinical reasoning, and progress over time, and should meet all jurisdictional regulatory standards.

Providers are encouraged to use a structured note format, such as the SOAP framework, to support consistency, clarity, and continuity of care.

Subjective: Document the patient’s reported symptoms, concerns, functional changes, contextual factors (e.g., psychosocial or environmental influences), and responses to prior care.

Objective: Record measurable or observable findings, including physical examination results, relevant diagnostic tests, functional assessments, and any clinically significant changes.

Assessment: Provide the clinical interpretation of findings, including diagnostic impressions or updates, identification of key risk factors or modifiers, and evaluation of the patient’s status or progression.

Plan: Outline the management strategy, including treatments delivered, modifications made, patient education and self-management recommendations, referrals, co-management decisions, and planned follow-up.

Documentation should be completed contemporaneously and maintained in accordance with regulatory requirements for privacy, security, and record retention. High-quality records support patient safety, facilitate interprofessional communication, enable shared decision-making, and promote continuity and accountability in care.

2. Informed Consent
  • Definition: A process where the patient voluntarily agrees to proposed healthcare interventions after receiving adequate information on the nature, benefits, risks, and alternatives.
  • Key Aspects:
    • Prior to interaction: Obtain consent before any diagnostic testing or treatment. Ensure the patient understands the planned examinations, treatments, expected outcomes, and is given the opportunity to ask questions.
    • Voluntarily and specific: Consent must be given willingly, without coercion, and pertain to the specific condition and proposed treatment. The patient should also understand that they can withdraw consent at any time. 
    • Transparent process: Consent must be obtained honestly, with a clear explanation of the condition and proposed interventions. Consent is not a one-time event, and involves ongoing discussions with the patient.
    • Patient understanding and agreement:
      • Diagnosis/prognosis: Explain findings clearly, using understandable language and visuals if needed.
      • Treatment plan: Outline recommended treatments and how they align with patient goals. Discuss benefits, risks, and alternatives.
      • Questions: Encourage questions and confirm understanding (e.g., “teach-back”).
    • Documentation: Record the consent process, including information provided, patient questions, and explicit consent given.
3. Health History
  • Apply cultural awareness and trauma-informed care principles.
  • Sociodemographic information: Age, gender, sex, race/ethnicity.
  • Main complaint: Location, onset, duration, and nature of orofacial, jaw, headache, or ear-related symptoms (e.g., ear pain, fullness, tinnitus); pain behavior with jaw movement (e.g., opening, chewing, yawning); presence of joint sounds (clicking, popping, crepitus); stiffness or restricted mandibular movement; and impact on eating, speaking, yawning, sleep, work, and daily activities.
  • Body systems: Neurologic, cardiovascular, genitourinary, gastrointestinal, musculoskeletal, bone density, eyes/ears/nose/throat, respiratory, skin, mental health, reproductive.
  • Health, lifestyle, and history: Past medical conditions; medications and supplements; history of facial, jaw, or cervical trauma; dental history (recent dental procedures, orthodontics); headache or migraine history; sleep quality and sleep disorders; parafunctional behaviors (e.g., clenching, bruxism, gum chewing); posture-related symptoms; physical activity and exercise history.
  • Social determinants of health: Employment, childcare, education, nutrition, housing, domestic violence, child maltreatment, discrimination, social isolation.
  • Previous treatments and responses: Prior conservative, dental, or medical treatments (e.g., splints, medications, physical therapy), adherence, perceived benefit, and adverse effects.
  • Beliefs and expectations: Understanding of TMD, beliefs about causes (e.g., bite, stress), expectations regarding recovery, concerns about chronicity, and confidence in jaw use and activity.
  • Flag considerations: Screen for red flags, orange flags, and psychosocial (yellow) factors.

​​Outcomes Assessments: Prioritize outcome measures that align with the individual’s goals, symptom profile, and functional limitations.

  • Pain: Use pain scales (e.g., NRS) and diagrams.
  • Function and Participation: Evaluate impact on daily activities (PSFS, WHODAS, MFIQ). Impact of symptoms on eating, communication, work, social participation, and daily activities.
  • Recovery: Use self-rated recovery scales.
  • Quality of life: Assess using tools such as SF-12.
  • Sleep quality: Assess using tools such as PSQI.
  • Work/school status: Monitor return to activities.
  • Individual goals: Set SMART goals (Specific, Measurable, Achievable, Relevant, Timely).
  • Patient feedback: Gather and integrate patient experience and satisfaction.
4. Red Flags : Differential Diagnosis Requiring Medical Referral

ACTION: Refer immediately to emergency care:

  • Suspected stroke or transient ischemic attack (TIA):
    Sudden onset of facial or limb weakness, numbness, dysarthria, aphasia, visual changes, ataxia, dizziness, vertigo, confusion, or severe headache.
  • Suspected infection involving the TMJ or adjacent structures:
    Acute onset of severe facial or jaw pain with redness, rapid swelling, warmth, fever, trismus, or systemic symptoms.
  • Suspected fracture or dislocation:
    History of facial trauma with malocclusion, inability to open or close the mouth, deformity, or acute functional loss.

ACTION: Refer to appropriate medical provider:

  • Giant cell arteritis (temporal arteritis):
    Age over 50 with new or atypical headache, jaw claudication, unexplained fever, scalp tenderness, or visual disturbance/loss.
  • Trigeminal neuralgia:
    Severe, unilateral, electric shock–like facial pain in the distribution of one or more branches of the trigeminal nerve.
  • Inflammatory or systemic disease:
    Features suggestive of inflammatory arthritis (e.g., rheumatoid arthritis, psoriatic arthritis), including prolonged morning stiffness, multi-joint involvement, or known systemic disease.
  • Neoplasm:
    Persistent or progressive facial or jaw pain, unexplained swelling, night pain, weight loss, or cranial nerve involvement.
  • Otologic or dental pathology:
    Persistent ear pain, hearing changes, vertigo, discharge, or dental symptoms inconsistent with referred pain.
  • Persistent or worsening symptoms:
    Progressive pain or functional decline not responding to appropriate conservative care, where diagnosis remains uncertain.
5. Orange Flags: Symptoms of Psychiatric Disorders Requiring Referral

Clinicians should promptly address symptoms of potential mental health disorders to prevent harm through appropriate and timely referrals.

ACTION: Refer for immediate care (emergency department, medical/mental health provider):

  • Suicidal ideation: Thoughts, plans, or statements about suicide or feelings of hopelessness.   
  • Severe, acute symptoms: Acute psychological distress, such as psychosis, severe panic.
  • Ideation of harm: Intent or plans to self-harm, commit violence, or harm others.

ACTION: Refer to appropriate medical/mental health provider:

  • Persistent, non-urgent symptoms: Symptoms affecting daily functioning (e.g., low mood, anxiety, sleep disturbances, social withdrawal, substance use).

ACTION: Co-management by non-medical/mental health providers:

  • Triage: Ensure primary management by medical/psychiatric providers.
  • Musculoskeletal (MSK) treatment: Manage MSK conditions related to or comorbid with psychological disorders.
  • Screening tools: Selectively use tools to monitor symptoms and severity, guide care, and support escalation without implying a diagnosis. Tools include:
    • PHQ-9 (depressive symptoms)
    • GAD-7 (anxiety symptoms)
    • FABQ (fear related to physical activity/work) 
    • PCS (catastrophic thoughts) 
    • ORT (opioid risk)
6. Yellow Flags: Psychosocial Factors that May Delay Recovery

Non-health barriers can delay recovery; early identification and intervention can enhance outcomes.

Factors:

  • Individual: Worry, fear of movement, low recovery expectations, limited self-efficacy, reliance on passive treatments, activity avoidance.
  • Social: Lack of family/social support, limited connections.
  • Socioeconomic: Employment status, financial stress, litigation/compensation.
  • Environmental/cultural: Social inequality, unsafe/unsupportive environments.
  • Life events: Major transitions (e.g., divorce, job loss), chronic stressors (e.g., caregiving).
  • Work/school: High stress, poor work-life balance, limited accommodations for injury/illness.

ACTION: Co-management by non-medical/mental health providers: 

  • Education & self-care: Provide resources for (e.g., stress management, coping strategies, graded activity).  
  • Monitor & coordinate: Regularly assess psychosocial challenges; refer to medical/mental health provider if persistent.
  • Screening tools: Selectively use tools to monitor symptoms and severity, guide care, and support escalation (aligned with Orange Flag guidance), without implying a diagnosis. Tools include:
    • PHQ-9 (depressive symptoms)
    • GAD-7 (anxiety symptoms)
    • FABQ (fear related to physical activity/work) 
    • PCS (catastrophic thoughts) 
    • ORT (opioid risk)

7. Physical Examination

The physical examination should be guided by the individual’s history, symptom behavior, and functional limitations, and findings should be interpreted in combination.

Observation

  • Facial symmetry, mandibular posture at rest, and habitual jaw position.
  • Visible deviation or deflection during mouth opening and closing.
  • Signs of guarding, altered movement patterns, or parafunctional behaviors.

Mandibular range of motion

  • Active and passive mouth opening, lateral deviation, and protrusion.
  • Presence of pain, restriction, asymmetry, or end-range discomfort.
  • Observation of joint sounds (clicking, popping, crepitus) during movement.

Palpation

  • Palpation of the temporomandibular joints for tenderness, swelling, or pain reproduction.
  • Palpation of masticatory muscles (e.g., masseter, temporalis, medial and lateral pterygoids where accessible) for tenderness, tone, or symptom reproduction.
  • Palpation of relevant cervical musculature as indicated.

Joint sounds

  • Identification of clicking, popping, or crepitus during mandibular movement.
  • Correlation of joint sounds with pain or functional limitation, recognizing that joint sounds alone are not diagnostic.

Neurological screening

  • Cranial nerve screening as indicated, particularly when facial sensory changes, weakness, or atypical symptoms are reported.
  • Screening for cervical or referred pain contributions where relevant.

Functional assessment

  • Assessment of pain and control during functional tasks such as chewing, speaking, yawning, or sustained mouth opening.
  • Evaluation of tolerance to jaw use in activities relevant to the individual’s goals and daily demands.

Cervical and postural assessment

  • Screening of cervical spine mobility and posture where neck symptoms coexist or contribute to symptom presentation.
  • Integration of findings with orofacial symptoms rather than isolated interpretation.

Special/orthopedic tests

  • Special or orthopedic tests (e.g., joint loading, assisted movement tests) may be performed selectively to support clinical reasoning.
  • Findings should be interpreted cautiously and in combination with history, symptom behavior, and functional assessment, recognizing that no single test is diagnostic for TMD.

Imaging and diagnostics

  • Imaging is not routinely indicated for most presentations of TMD.
  • Radiography or advanced imaging may be considered when there is suspicion of fracture, dislocation, inflammatory, or when symptoms are atypical, progressive, or unresponsive to appropriate conservative care.
  • Imaging findings should be interpreted in clinical context, as structural changes do not consistently correlate with pain or dysfunction.
8. Clinical Presentations of TMD

There is no single, widely accepted test to definitively diagnose temporomandibular disorders. Clinical reasoning should be based on a combination of history, symptom behavior, and examination findings, recognizing that presentations often overlap and may change over time (Beaumont 2020).

Common clinical presentation patterns include:

Muscle-dominant presentations (myalgia / myofascial pain)

  • Pain localized to the masticatory musculature
  • Pain reproduced with palpation of muscles of mastication
  • Pain or limitation with mouth opening or lateral/protrusive movements
  • Jaw fatigue or stiffness with use

Joint-dominant presentations (arthralgia)

  • Pain localized to the temporomandibular joint
  • Pain reproduced with TMJ palpation
  • Pain with mouth opening, lateral deviation, or protrusion
  • Joint sounds may or may not be present

Disc-related mechanical presentations

  • Symptoms may fluctuate and are not always painful
  • Audible joint sounds (clicking, popping, snapping) during opening, closing, or lateral/protrusive movements
  • Episodes of jaw locking or limited opening
  • Symptoms may fluctuate and are not always painful

Degenerative joint presentations

  • Crepitus during active or passive jaw movement
  • Possible reduction in mandibular range of motion
  • Symptoms may or may not correlate with imaging findings

Hypermobility or instability presentations

  • History of joint “catching,” locking, or dislocation
  • Difficulty closing the mouth from a fully open position
  • In some cases, inability to return to a closed position without assistance

Headache attributed to TMD

  • Headache localized to the temporal region
  • Headache provoked or modified by jaw movement, sustained jaw use, or parafunctional behaviors
  • Familiar headache reproduced with palpation of the temporalis muscle or mandibular movements

These presentation patterns are not mutually exclusive, and individuals may demonstrate features of more than one pattern. Structural findings, occlusal characteristics, and imaging abnormalities do not reliably predict pain severity or functional impact.

9. Conservative Treatment Considerations for TMD

Approach to Treatment

The treatments outlined in this section reflect core domains of care consistently supported by high-quality clinical practice guidelines. Management should be individualized, taking into account symptom duration, clinical presentation, functional impact, patient goals, and response to care.

Not all domains are required for every individual or at every stage of recovery. Clinicians are expected to apply professional judgment in selecting the most appropriate components of care.

This pathway is not prescriptive and does not list all possible interventions. Interventions with limited or inconsistent evidence (particularly passive or invasive procedures) are not recommended for routine use and, if considered, should be used only as adjuncts to core, evidence-based care.

Acute and Subacute TMD 

Evidence specific to acute TMD is limited; however, expert consensus and extrapolation from chronic TMD and musculoskeletal pain literature support an initial conservative, low-risk approach.

Recommended early management

  • Education and reassurance regarding the generally favourable prognosis
  • Advice to avoid excessive jaw loading (e.g., prolonged chewing, clenching, gum chewing)
  • Gentle jaw range-of-motion and relaxation exercises within tolerance
  • Postural awareness and avoidance of sustained jaw or cervical strain
  • Short-term use of simple analgesics or NSAIDs, if appropriate and not contraindicated
  • Monitoring of symptom trajectory and functional impact

Early escalation to invasive or irreversible interventions is not recommended. Persistence of symptoms beyond several weeks, worsening pain, or increasing functional limitation should prompt reassessment and transition to a chronic-care framework.

Persistent TMD (Busse et al., 2023)

Strong recommendations in favour

  • Cognitive behavioural therapy (CBT)
    Including CBT alone or CBT augmented with relaxation therapy or biofeedback. CBT targets pain coping, maladaptive beliefs, stress responses, and activity avoidance, and is associated with meaningful improvements in pain and function.
  • Therapist-assisted jaw mobilization
    Gentle, guided mobilization aimed at improving jaw movement and reducing pain.
  • Manual trigger point therapy
    Directed at masticatory muscles to reduce pain sensitivity and improve function.
  • Supervised postural exercise
    Exercises addressing cervical and upper-quarter posture and movement control.
  • Supervised jaw exercise and stretching
    With or without manual trigger point therapy, targeting jaw mobility, endurance, and control.
  • Usual care
    Defined as education, reassurance, self-management advice, home exercises and stretching, and self-massage.

Conditional recommendations in favour

  • Manipulation
    Considered selectively and integrated within a broader care plan.
  • Acupuncture
    May provide modest benefit for pain and function in some individuals.
  • Jaw exercise combined with mobilization
  • Manipulation combined with postural exercise
  • CBT combined with NSAIDs
    Where medication risks are acceptable and NSAIDs are used short-term.

Conditional recommendations against

The following are not recommended for routine use, due to limited benefit, potential harm, or unfavourable risk–benefit balance:

  • Reversible occlusal splints (alone or in combination)
  • Arthrocentesis (alone or in combination)
  • Low-level laser therapy
  • Transcutaneous electrical nerve stimulation (TENS)
  • Gabapentin
  • Botulinum toxin injections
  • Hyaluronic acid injections (with or without supplements)
  • Relaxation therapy alone or biofeedback alone
  • Trigger point injections
  • Acetaminophen (alone or combined with muscle relaxants or NSAIDs)
  • Topical capsaicin
  • Corticosteroid injections (with or without NSAIDs)
  • Benzodiazepines and beta-blockers

Strong recommendations against

  • Irreversible oral splints
  • Discectomy
  • NSAIDs combined with opioids
10. Risk and Prognostic Factors for TMD

(Beaumont et al., 2020; Durham et al., 2015; Busse et al., 2023; Felin et al., 2022)

TMD has a variable clinical course, with prognosis influenced by a combination of biological, psychological, and contextual factors rather than by structural findings alone

Common risk factors

  • History of trauma to the jaw, face, or neck, including falls, sports injuries, interpersonal violence, or prolonged dental procedures.
  • Parafunctional behaviours such as clenching or bruxism.

Psychological and pain-related factors

  • Psychological comorbidities, including anxiety, depression, and somatization, are common among individuals with TMD and are strongly associated with pain persistence and disability.
  • Psychological comorbidities, including anxiety, depression, and somatization, are common among individuals with TMD, particularly in those with persistent symptoms, and are associated with poorer outcomes and increased disability.

Prognostic considerations

  • While many individuals with acute TMD improve with conservative care, up to approximately 30% may develop persistent symptoms lasting longer than three months.
  • Poorer outcomes are associated with higher baseline pain, psychological distress, widespread pain, and maladaptive coping, rather than with imaging findings or occlusal characteristics.

Recognition of these factors can support early reassurance, appropriate expectation-setting, and timely integration of behavioural and self-management strategies for individuals at higher risk of persistent symptoms.

11. Ongoing Follow-up
  • Monitor progress: Reassess symptoms, functional status, and patient-reported outcomes at appropriate intervals. Confirm that care remains aligned with the patient’s goals, values, and expectations.
  • Adjust treatment plan: Continuously realign the management plan based on evolving goals, treatment response, clinical findings, and professional judgment. Modify interventions, dosage, frequency, or focus as needed to support meaningful improvement.
  • Support self-management: Reinforce the patient’s understanding of home strategies, activity recommendations, and behavioural approaches. Encourage adherence and address barriers that may affect progress.
  • Recognize plateaus or change in status: Identify when the patient is improving, stable, or worsening. Reassess for contributing factors such as comorbidities, psychosocial influences, or new functional limitations.
  • Referral and co-management: Consider referral or co-management with an appropriate provider when there is limited or no significant improvement within an expected timeframe (for example 6 to 8 weeks), when new or concerning findings emerge, or when additional expertise is required to support optimal care.
  • Documentation: Record follow-up assessments, changes to the plan, patient feedback, reassessment of goals, and any referral or co-management decisions.
12. Criteria for Discharge
  • Discharge criteria: Establish clear criteria for concluding active care. These may include achieving the patient’s initial goals, demonstrating meaningful improvement in symptoms or function, reaching a plateau in progress, or transitioning to self-management as the primary approach. Consider patient preferences, functional demands, and clinical judgment when determining readiness for discharge.
  • Clinical reassessment: Prior to discharge, complete a focused reassessment to confirm stability of symptoms, functional status, and the patient’s confidence in managing their condition. Address any remaining concerns and ensure no new issues require further evaluation.
  • Post-discharge planning: Discuss ongoing self-management strategies, including activity recommendations, home exercises, behavioural or lifestyle modifications, and symptom monitoring. Provide guidance on when to return for follow-up, when to seek additional care, and what indicators should prompt medical evaluation.
  • Future care needs: Clarify options for episodic care, preventive visits, or re-engagement with the provider if symptoms recur or functional demands change. Encourage ongoing communication if new concerns arise.
  • Documentation: Record the rationale for discharge, the patient’s status at the time of discharge, self-management recommendations provided, and the agreed-upon follow-up plan